MedTech Industry Dynamics
MedTech Industry Dynamics
Insightec has launched Lotus Neuro as a new clinical-stage biotech focused on using low-frequency focused ultrasound to support brain-targeted drug delivery, with initial programs in neuro-oncology.
Meer lezenYAS Healthcare has partnered with IBA to bring the first Proteus®ONE proton therapy system to Dubai, marking a significant advancement in cancer treatment in the UAE.
Meer lezenNexalin Technology has appointed Carmi Masha Technologies as its exclusive Israeli distributor following national regulatory approval for the company’s Gen-2 SYNC neurostimulation device.
Meer lezenAISAP has launched an AI-driven cardiac diagnostic program in Ghana, combining specialist training and advanced technology to improve early heart disease detection and provide a scalable model for global rural healthcare.
Meer lezenBoston-based Elevaris Medical Devices will debut at COMPAMED 2025 in Düsseldorf, introducing its contract development and manufacturing services along with a comprehensive procedural needle portfolio for the EMEA market.
Meer lezenIsrael-based CustoMED has secured $6 million in seed funding to expand its AI-powered, surgeon-directed platform that converts medical imaging into patient-specific surgical tools and implants in real time.
Meer lezenOlympus has introduced THUNDERBEAT II, its next-generation hybrid energy device for open and laparoscopic surgery, offering faster hemostatic dissection, secure vessel sealing, and improved thermal control across the EMEA region.
Meer lezenTechsomed and Medtronic have entered a pilot collaboration integrating Techsomed’s BioTraceIO360 software with Medtronic’s Emprint microwave ablation system to enhance precision and efficiency in image-guided ablation therapy.
Meer lezenSaudi German Health has expanded its collaboration with Mayo Clinic, adding new hospitals in the UAE and Egypt and planning further network growth across Saudi Arabia to strengthen specialty care and clinical transformation programs.
Meer lezenIceCure Medical has received regulatory approval in Israel for its next-generation XSense cryoablation system, including for breast cancer treatment.
Meer lezen
